Juventas Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 5

CIPO Patents = 1

EPO Patents = 2

Forward Citations = 17

Loading Chart...

5 inventors (with patents filed for the assignee):

Marc S Penn (5 out of 24 patents)

Rahul Aras (5 out of 5 patents)

Joseph M Pastore (5 out of 94 patents)

4. Timothy J Miller (4 out of 35 patents)

5. Matthew Kiedrowski (1 out of 4 patents)

5 patents: Sort by Forward Citations

1. 9844581 - SDF-1 delivery for treating ischemic tissue (2017-12-19),

2. 8883756 - SDF-1 delivery for treating ischemic tissue (2014-11-11),

3. 8679477 - Use of SDF-1 to mitigate scar formation (2014-03-25),

4. 8513213 - SDF-1 delivery for treating ischemic tissue (2013-08-20),

5. 8513007 - SDF-1 delivery for treating ischemic tissue (2013-08-20),

Company Overview

Juventas Therapeutics, Inc. is a biotechnology company focused on developing regenerative therapies for cardiovascular diseases. Their groundbreaking research aims to harness the body's own healing mechanisms to treat conditions such as heart failure and peripheral artery disease. With a strong emphasis on innovation and patient care, Juventas Therapeutics is dedicated to improving the lives of those affected by cardiovascular disorders.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#252 in Cleveland, OH

#2,007 in Ohio

#51,669 in US

Cleveland, OH, United States of America

Juventas Therapeutics, Inc.

Forward Citations = 17

5 inventors:

Marc S Penn (5 out of 24 patents)

Rahul Aras (5 out of 5 patents)

Joseph M Pastore (5 out of 94 patents)

4. Timothy J Miller (4 out of 35 patents)

5. Matthew Kiedrowski (1 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Juventas Therapeutics, Inc.. Retrieved from https://idiyas.com/company/juventas-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]